Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of combination therapy with ranibizumab (RBZ) and panretinal
photocoagulation (PRP) versus PRP alone in patients with treatment-naive bilateral
proliferative diabetic retinopathy (PDR) as measured by mean change in visual acuity (VA),
mean change in central retinal thickness (CRT) as measured by time-domain optic coherence
tomography (TD-OCT) and incidence of vitreous hemorrhage (VH).